Atorvastatin prevents cell damage via modulation of oxidative stress, glutamate uptake and glutamine synthetase activity in hippocampal slices subjected to oxygen/glucose deprivation

Neurochemistry International

Volumn 62, Issue 7, 2013, Pages 948-955

  Vandresen Filho, Samuel ^a,b   Martins, Wagner C ^a   Bertoldo, Daniela B ^a   Mancini, Gianni ^a   Herculano, Bruno A ^a   De Bem, Andreza F ^a   Tasca, Carla I ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

Author keywords

Atorvastatin; Glutamate uptake; Neuroprotection; Oxidative stress; Oxygen glucose deprivation

Indexed keywords

ATORVASTATIN; GLUCOSE; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; OXYGEN; REACTIVE OXYGEN METABOLITE; THIOL GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN SLICE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; EX VIVO STUDY; EXCITOTOXICITY; HIPPOCAMPUS; IN VIVO STUDY; MALE; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NEUROTRANSMITTER UPTAKE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REOXYGENATION;

ANIMALS; CELL DEATH; GLUCOSE; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; HEPTANOIC ACIDS; HIPPOCAMPUS; MALE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXYGEN; PYRROLES; REACTIVE OXYGEN SPECIES;

EID: 84875930576     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.03.002     Document Type: Article

References (68)

1. M. Arundine, and M. Tymianski Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury Cell. Mol. Life Sci. 61 2004 657 668
2. M. Asahi, Z. Huang, S. Thomas, S. Yoshimura, T. Sumii, T. Mori, J. Qiu, S. Amin-Hanjani, P.L. Huang, J.K. Liao, E.H. Lo, and M.A. Moskowitz Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia J. Cereb. Blood Flow Metab. 25 2005 722 729
3. E. Barone, G. Cenini, F. Di Domenico, S. Martin, R. Sultana, C. Mancuso, M.P. Murphy, E. Head, and D.A. Butterfield Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action Pharmacol. Res. 63 2011 172 180
4. C. Berger, F. Xia, M.H. Maurer, and S. Schwab Neuroprotection by pravastatin in acute ischemic stroke in rats Brain. Res. Rev. 58 2008 48 56
5. N.R. Bhat, and J.J. Volpe Relation of cholesterol to astrocytic differentiation in C-6 glial cells J. Neurochem. 42 1984 1457 1463
6. T. Borisova, N. Krisanova, R. Sivko, and A. Borysov Cholesterol depletion attenuates tonic release but increases the ambient level of glutamate in rat brain synaptosomes Neurochem. Int. 56 2010 466 478
7. J. Bosel, F. Gandor, C. Harms, M. Synowitz, U. Harms, P.C. Djoufack, D. Megow, U. Dirnagl, H. Hortnagl, K.B. Fink, and M. Endres Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones J. Neurochem. 92 2005 1386 1398
8. K. Brongholi, D.G. Souza, A.C. Bainy, A.L. Dafre, and C.I. Tasca Oxygen-glucose deprivation decreases glutathione levels and glutamate uptake in rat hippocampal slices Brain Res. 1083 2006 211 218
9. V.M. Bruno, M.P. Goldberg, L.L. Dugan, R.G. Giffard, and D.W. Choi Neuroprotective effect of hypothermia in cortical cultures exposed to oxygen-glucose deprivation or excitatory amino acids J. Neurochem. 63 1994 1398 1406
10. M.E. Butchbach, G. Tian, H. Guo, and C.L. Lin Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function J. Biol. Chem. 279 2004 34388 34396
11. D.W. Choi Glutamate neurotoxicity and diseases of the nervous system Neuron 1 1988 623 634
12. L. Cibickova, R. Hyspler, S. Micuda, N. Cibicek, H. Zivna, D. Jun, A. Ticha, E. Brcakova, and V. Palicka The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain Steroids 74 2009 13 19
13. R.M. Clarke, F. O'Connell, A. Lyons, and M.A. Lynch The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo Neuropharmacology 52 2007 136 145
14. A.P. Costa, A.C. Tramontina, R. Biasibetti, C. Batassini, M.W. Lopes, K.M. Wartchow, C. Bernardi, L.S. Tortorelli, R.B. Leal, and C.A. Goncalves Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia Behav. Brain Res. 226 2012 420 427
15. T. Dal-Cim, W.C. Martins, A.R. Santos, and C.I. Tasca Guanosine is neuroprotective against oxygen/glucose deprivation in hippocampal slices via large conductance Ca(2)+-activated K+ channels, phosphatidilinositol-3 kinase/protein kinase B pathway activation and glutamate uptake Neuroscience 183 2011 212 220
16. N.C. Danbolt Glutamate uptake Prog. Neurobiol. 65 2001 1 105
17. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
18. H. Endou, Y. Kanai, N. Utsunomiya-Tate, and M. Hosoyamada A novel Na(+)-dependent amino acid transporter with a high affinity to glutamine Contrib. Nephrol. 121 1997 31 36
19. T. Hayashi, K. Hamakawa, S. Nagotani, G. Jin, F. Li, K. Deguchi, Y. Sehara, H. Zhang, I. Nagano, M. Shoji, and K. Abe HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons Brain Res. 1037 2005 52 58
20. S.L. Hempel, G.R. Buettner, Y.Q. O'Malley, D.A. Wessels, and D.M. Flaherty Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123 Free Radic. Biol. Med. 27 1999 146 159
21. L. Hertz, and H.R. Zielke Astrocytic control of glutamatergic activity: astrocytes as stars of the show Trends Neurosci. 27 2004 735 743
22. D.C. Hess, A.M. Demchuk, L.M. Brass, and F.M. Yatsu HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention Neurology 54 2000 790 796
23. H. Homma Biochemistry of d-aspartate in mammalian cells Amino Acids 32 2007 3 11
24. A. Hoshi, T. Nakahara, H. Kayama, and T. Yamamoto Ischemic tolerance in chemical preconditioning: possible role of astrocytic glutamine synthetase buffering glutamate-mediated neurotoxicity J. Neurosci. Res. 84 2006 130 141
25. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 2000 1627 1631
26. Y. Kanai, and M.A. Hediger The glutamate and neutral amino acid transporter family: physiological and pharmacological implications Eur. J. Pharmacol. 479 2003 237 247
27. E. Kosenko, M. Llansola, C. Montoliu, P. Monfort, R. Rodrigo, M. Hernandez-Viadel, S. Erceg, A.M. Sanchez-Perez, and V. Felipo Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide Neurochem. Int. 43 2003 493 499
28. U. Laufs, K. Gertz, U. Dirnagl, M. Bohm, G. Nickenig, and M. Endres Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice Brain Res. 942 2002 23 30
29. J.H. Lim, J.C. Lee, Y.H. Lee, I.Y. Choi, Y.K. Oh, H.S. Kim, J.S. Park, and W.K. Kim Simvastatin prevents oxygen and glucose deprivation/reoxygenation- induced death of cortical neurons by reducing the production and toxicity of 4-hydroxy-2E-nonenal J. Neurochem. 97 2006 140 150
30. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
31. D. Lu, A. Goussev, J. Chen, P. Pannu, Y. Li, A. Mahmood, and M. Chopp Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury J. Neurotrauma 21 2004 21 32
32. F.K. Ludka, A.D. Zomkowski, M.P. Cunha, T. Dal-Cim, A.L. Zeni, A.L. Rodrigues, and C.I. Tasca Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels Eur. Neuropsychopharmacol. 2012 http://dx.doi.org/10.1016/j.euroneuro.2012.05.005
33. E.B. Malarkey, and V. Parpura Mechanisms of glutamate release from astrocytes Neurochem. Int. 52 2008 142 154
34. H. Miao, S.S. Rubakhin, C.R. Scanlan, L. Wang, and J.V. Sweedler d-Aspartate as a putative cell-cell signaling molecule in the Aplysia californica central nervous system J. Neurochem. 97 2006 595 606
35. S. Molz, H. Decker, I.J. Oliveira, D.O. Souza, and C.I. Tasca Neurotoxicity induced by glutamate in glucose-deprived rat hippocampal slices is prevented by GMP Neurochem. Res. 30 2005 83 89
36. S. Molz, H. Decker, T. Dal-Cim, C. Cremonez, F.M. Cordova, R.B. Leal, and C.I. Tasca Glutamate-induced toxicity in hippocampal slices involves apoptotic features and p38 MAPK signaling Neurochem. Res. 33 2008 27 36
37. S. Molz, T. Dal-Cim, J. Budni, M.D. Martin-de-Saavedra, J. Egea, A. Romero, L. del Barrio, A.L. Rodrigues, M.G. Lopez, and C.I. Tasca Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase 3beta pathway activation and inducible nitric oxide synthase inhibition J. Neurosci. Res. 89 2011 1400 1408
38. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
39. S. Nakatsuka, M. Hayashi, A. Muroyama, M. Otsuka, S. Kozaki, H. Yamada, and Y. Moriyama d-Aspartate is stored in secretory granules and released through a Ca(2+)-dependent pathway in a subset of rat pheochromocytoma PC12 cells J. Biol. Chem. 276 2001 26589 26596
40. Y. Nishizawa Glutamate release and neuronal damage in ischemia Life Sci. 69 2001 369 381
41. C.N. Oliver, P.E. Starke-Reed, E.R. Stadtman, G.J. Liu, J.M. Carney, and R.A. Floyd Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain Proc. Natl. Acad. Sci. USA 87 1990 5144 5147
42. N. Ota, T. Shi, and J.V. Sweedler d-Aspartate acts as a signaling molecule in nervous and neuroendocrine systems Amino Acids 43 2012 1873 1886
43. T.C. Piermartiri, S. Vandresen-Filho, B. de Araujo Herculano, W.C. Martins, D. Dal'agnolo, E. Stroeh, C.L. Carqueja, C.R. Boeck, and C.I. Tasca Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake Neurotox. Res. 16 2009 106 115
44. T.C. Piermartiri, C.P. Figueiredo, D. Rial, F.S. Duarte, S.C. Bezerra, G. Mancini, A.F. de Bem, R.D. Prediger, and C.I. Tasca Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-beta(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage Exp. Neurol. 226 2010 274 284
45. J. Ponce, N.P. de la Ossa, O. Hurtado, M. Millan, J.F. Arenillas, A. Davalos, and T. Gasull Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection Stroke 39 2008 1269 1275
46. R. Rodrigo, and V. Felipo Control of brain glutamine synthesis by NMDA receptors Front. Biosci. 12 2007 883 890
47. D.J. Rossi, T. Oshima, and D. Attwell Glutamate release in severe brain ischaemia is mainly by reversed uptake Nature 403 2000 316 321
48. P. Saransaari, and S.S. Oja Mechanisms of d-aspartate release under ischemic conditions in mouse hippocampal slices Neurochem. Res. 24 1999 1009 1016
49. R. Sattler, and M. Tymianski Molecular mechanisms of calcium-dependent excitotoxicity J. Mol. Med. (Berl) 78 2000 3 13
50. R. Sattler, and M. Tymianski Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death Mol. Neurobiol. 24 2001 107 129
51. B.M. Shapiro Regulation of glutamine synthetase by enzyme catalyzed structural modification Angew. Chem. Int. Ed. Engl. 9 1970 670 678
52. E.R. Stadtman, A. Ginsburg, J.E. Ciardi, J. Yeh, S.B. Hennig, and B.M. Shapiro Multiple molecular forms of glutamine synthetase produced by enzyme catalyzed adenylation and deadenylylation reactions Adv. Enzyme Regul. 8 1970 99 118
53. D.B. Stanimirovic, R. Ball, D.L. Small, and A. Muruganandam Developmental regulation of glutamate transporters and glutamine synthetase activity in astrocyte cultures differentiated in vitro Int. J. Dev. Neurosci. 17 1999 173 184
54. E.V. Stelmashook, N.K. Isaev, E.R. Lozier, E.S. Goryacheva, and L.G. Khaspekov Role of glutamine in neuronal survival and death during brain ischemia and hypoglycemia Int. J. Neurosci. 121 2011 415 422
55. U. Strasser, and G. Fischer Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/glucose deprivation J. Neurosci. Methods 57 1995 177 186
56. G. Tian, Q. Kong, L. Lai, A. Ray-Chaudhury, and C.L. Lin Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease J. Neurochem. 113 2010 978 989
57. H.I. Tsai, L.H. Tsai, M.Y. Chen, and Y.C. Chou Cholesterol deficiency perturbs actin signaling and glutamate homeostasis in hippocampal astrocytes Brain Res. 1104 2006 27 38
58. Q. Wang, A. Zengin, C. Deng, Y. Li, K.A. Newell, G.Y. Yang, Y. Lu, E.P. Wilder-Smith, H. Zhao, and X.F. Huang High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: the association with the up-regulation of NMDA receptor binding in the rat brain Exp. Neurol. 216 2009 132 138
59. E.A. Waxman, and D.R. Lynch N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease Neuroscientist 11 2005 37 49
60. B. Wolozin, W. Kellman, P. Ruosseau, G.G. Celesia, and G. Siegel Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitors Arch. Neurol. 57 2000 1439 1443
61. J. Yan, Y. Xu, C. Zhu, L. Zhang, A. Wu, Y. Yang, Z. Xiong, C. Deng, X.F. Huang, M.A. Yenari, Y.G. Yang, W. Ying, and Q. Wang Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses PLoS One 6 2011 e20945
62. J. Yrjanheikki, J. Koistinaho, M. Kettunen, R.A. Kauppinen, K. Appel, M. Hull, and B.L. Fiebich Long-term protective effect of atorvastatin in permanent focal cerebral ischemia Brain Res. 1052 2005 174 179
63. A. Zacco, J. Togo, K. Spence, A. Ellis, D. Lloyd, S. Furlong, and T. Piser 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity J. Neurosci. 23 2003 11104 11111
64. F.L. Zhang, and P.J. Casey Protein prenylation: molecular mechanisms and functional consequences Annu. Rev. Biochem. 65 1996 241 269
65. W. Zhang, Y. Miao, S. Zhou, J. Jiang, Q. Luo, and Y. Qiu Neuroprotective effects of ischemic postconditioning on global brain ischemia in rats through upregulation of hippocampal glutamine synthetase J. Clin. Neurosci. 18 2011 685 689
66. M.H. Zhou, G. Yang, S. Jiao, C.L. Hu, and Y.A. Mei Cholesterol enhances neuron susceptibility to apoptotic stimuli via cAMP/PKA/CREB-dependent up-regulation of Kv2.1 J. Neurochem. 120 2011 502 514
67. F. Zipp, S. Waiczies, O. Aktas, O. Neuhaus, B. Hemmer, B. Schraven, R. Nitsch, and H.P. Hartung Impact of HMG-CoA reductase inhibition on brain pathology Trends Pharmacol. Sci. 28 2007 342 349
68. J. Zou, Y.X. Wang, F.F. Dou, H.Z. Lu, Z.W. Ma, P.H. Lu, and X.M. Xu Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons Neurochem. Int. 56 2010 577 584